Click here to

DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.

3 | A | B | C | D | E | F | G | H | I | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | show all

Keywords: Tumor Control
PO-GePV-I-89Preclinical Tumor Growth Delay Is More Reliably Derived From Imaging-Based Volume Measurements Than Manual Caliper Measurements
M Shotbolt*, J Castro, B Spieler, S Welford, I Mihaylov, University of Miami, Miami, FL
PO-GePV-M-22Personalization of Patient Specific Radiation Dose and Dose Fractionation Using Volumetric Tumor Dynamics
H Enderling1*, M Zahid1, E Moros1, J Caudell1, A Mohamed2, C Fuller2, (1) H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL,(2) UT MD Anderson Cancer Center, Houston, TX, (6) UT MD Anderson Cancer Center, Houston, TX
PO-GePV-M-274Finite Element Analysis of Customized Alternating Electric Fields Transducers for Small Animal Applications
H Nguyen1*, Y Zeng2, C Pohling3, VA Bashkirov3, Y Nie4, E Chang5, V Yamamoto6, KE Schubert1, CB Patel7, RW Schulte3, (1) Department of Electrical and Computer Engineering, Baylor University, TX, USA, (2) Department of Electrical and Computer Engineering, University of Delaware, DE, USA, (3) Division of Biomedical Engineering Sciences, Loma Linda University School of Medicine, CA, USA, (4) Department of Neurosurgery, Loma Linda University School of Medicine, CA, USA, (5) Molecular Imaging Program at Stanford, Department of Radiology, Stanford University School of Medicine, CA, USA, (6) USC-Norris Comprehensive Cancer Center, USC-Keck School of Medicine, CA, USA, (7) Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, TX, USA
PO-GePV-T-117Tumor Control Probability for Stereotactic Body Radiotherapy of Early Stage Hepatocellular Carcinoma
F Liu*, M Munley, Wake Forest University School of Medicine, Winston-salem, NC
SU-H430-IePD-F7-3Do Machine Learning-Based Models Perform Better Than Clinical Models in Predicting Biochemical Outcome for Prostate Cancer Patients?
L Sun1,2*, H Quon1,2, W Smith1,2, and C Kirkby1,3 (1) University of Calgary, Calgary, AB, CA (2) Tom Baker Cancer Centre, Calgary, AB, CA (3) Jack Ady Cancer Centre, Lethbridge, AB, CA
SU-K-202-3Efficacy and Photon Energy Dependency of In-Vivo Radiodynamic Therapy (RDT) with 5-Aminolevulinic Acid (5-ALA)
D Yang*, D Cvetkovic, T Dos Santos, L Chen, C Ma, Fox Chase Cancer Center, Philadelphia, PA
WE-B-BRC-13D Organoids as a Model to Study and Predict the Response of Pancreatic Cancer to Radiation Therapy
J Polf*, H Shukla, T Dukic, S Roy, B Bhandary, N Lamichhane, University of Maryland School of Medicine, Baltimore, MD
WE-C1000-IePD-F7-2Hypofractionated Radiotherapy Regimens for Early Stage Non-Small Cell Lung Cancer
F Liu*, M Munley, Wake Forest University School of Medicine, Winston-salem, NC

Share: